The effect of experimental design on the modeling of a tablet coating formulation using artificial neural networks

European Journal of Pharmaceutical Sciences

Volumn 16, Issue 4-5, 2002, Pages 281-288

  Plumb, A Philip ^a   Rowe, Raymond C ^b   York, Peter ^b   Doherty, Christopher ^a  

^a ASTRAZENECA   (United Kingdom)

^b UNIVERSITY OF BRADFORD   (United Kingdom)

Author keywords

Artificial neural network; Experimental design; Film coat formulation

Indexed keywords

COATINGS; FORECASTING; INTERPOLATION; MULTILAYER NEURAL NETWORKS; OPACITY; PARTICLE SIZE ANALYSIS; THICK FILMS;

CRACK VELOCITIES;

DRUG PRODUCTS;

ARTICLE; ARTIFICIAL NEURAL NETWORK; DRUG COATING; EXPERIMENTAL DESIGN; FILM; PARTICLE SIZE; PREDICTION; PRIORITY JOURNAL; SURFACE PROPERTY; THEORETICAL MODEL; THICKNESS; VALIDATION PROCESS; VELOCITY;

DRUG DESIGN; DRUG STABILITY; MODELS, CHEMICAL; NEURAL NETWORKS (COMPUTER); TABLETS, ENTERIC-COATED;

EID: 0036741551     PISSN: 09280987     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0928-0987(02)00112-4     Document Type: Article

References (23)

1. Achanta A.S., Kowalski J.G., Rhodes C.T. Artificial neural networks: implications for pharmaceutical sciences. Drug Dev. Ind. Pharm. 21:1995;119-155.
2. Agatonovic-Kustrin S., Wu V., Rades T., Saville D., Tucker I.G. Ranitidine hydrochloride X-ray assay using a neural network. J. Pharm. Biomed. Anal. 22:2000;985-992.
3. Agatonovic-Kustrin S., Beresford R., Razzak M. Determination of enantiomeric composition of ibuprofen in solid state mixtures of the two by DRIFT spectroscopy. Anal. Chim. Acta. 417:2000;31-39.
4. Bourquin J., Schmidli H., van Hoogevest P., Leuenberger H. Basic concepts of artificial neural networks (ANN) modeling in the application to pharmaceutical development. Pharm. Dev. Tech. 2:1997;95-109.
5. Bourquin J., Schmidli H., van Hoogevest P., Leuenberger H. Application of artificial neural networks (ANN) in the development of solid dosage forms. Pharm. Dev. Tech. 2:1997;111-121.
6. Bourquin J., Schmidli H., van Hoogevest P., Leuenberger H. Comparison of artificial neural networks (ANN) with classical modelling techniques using different experimental designs and data from a galenical study on a solid dosage form. Eur. J. Pharm. Sci. 6:1998;287-300.
7. Bourquin J., Schmidli H., van Hoogevest P., Leuenberger H. Advantages of artificial neural networks (ANNs) as alternative modelling technique for data sets showing non-linear relationships using data from a galenical study on a solid dosage form. Eur. J. Pharm. Sci. 7:1998;5-16.
8. Bourquin J., Schmidli H., van Hoogevest P., Leuenberger H. Pitfalls of artificial neural networks (ANN) modelling technique for data sets containing outlier measurements using a study on mixture properties of a direct compressed dosage form. Eur. J. Pharm. Sci. 7:1998;17-28.
9. Chen Y., McCall T.W., Baichwal A.R., Meyer M.C. The application of an artificial neural network and pharmacokinetic simulations in the design of controlled-release dosage forms. J. Controlled Release. 59:1999;33-41.
10. Colbourn E.A. The CAD/Chem formulation design and optimisation program. Rowe R.C. Roberts R.J. Intelligent Software for Product Formulation. 1998;77-94 Taylor and Francis London.
11. Colbourn E.A., Rowe R.C. Modelling and optimization of a tablet formulation using neural networks and genetic algorithms. Pharm. Tech. Eur. 8:1996;46-55.
12. Ebube N.K., McCall T., Chen Y., Meyer M.C. Relating formulation variables to in vitro dissolution using an artificial neural network. Pharm. Dev. Tech. 2:1997;225-232.
13. Hussain A.S., Shivanand P., Johnson R.D. Application of neural computing in pharmaceutical product development: computer aided formulation design. Drug Dev. Ind. Pharm. 20:1994;1739-1752.
14. Kesavan J.G., Peck G.E. Pharmaceutical formulation using neural networks. Proceedings of the 14th Pharmacy Technology Conference. Barcelona, Spain. 2:1995;413-431.
15. Myers R.H., Montgomery D.C. Response Surface Methodology, Process and Product Optimization Using Designed Experiments. 1995;Wiley New York.
16. Plumb A.P., Rowe R.C., York P., Doherty C. Aspects of training of an artificial neural network for the modelling of tablet coating formulations. J. Pharm. Pharmacol. 51:Suppl 1999;92.
17. Rowe R.C. Knowledge representation in the prediction of the opacity of tablet film coatings containing titanium dioxide. Eur. J. Pharm. Biopharm. 41:1995;215-218.
18. Rowe R.C., Roberts R.J. Simulation of crack propagation in tablet film coatings containing pigments. Int. J. Pharm. 78:1992;49-57.
19. Rowe R.C., Roberts R.J. The effect of some formulation variables on crack propagation in pigmented tablet film coatings using computer simulation. Int. J. Pharm. 86:1992;49-58.
20. Rowe R.C., Roberts R.J. Crack propagation in both porous compacts and pigmented films prepared from cellulose derivatives - a comparison of computer simulation with observation. Cellulose. 3:1996;11-20.
21. Taransenko L. A Guide To Neural Computing Applications. 1998;Arnold London.
22. Wasserman P. Neural Computing, Theory and Practice. 1989;Van Norstrand Reinhold New York.
23. Xu F., Sun L.X., Liang J.G., Liang Y.Z. Artificial neural network as applied to the analysis of chlorpromazine tablets. Acta Pharm. Sinica. 29:1994;767-772.